C12Y111/01006

COMPOSITIONS AND METHODS FOR TREATING THYROID DISEASE
20170290894 · 2017-10-12 · ·

The present disclosure relates to a compound and method of using such compound, preferably in the form of a dietary supplement that, when administered, is capable of treating thyroid disease and various thyroid-related disorders, such as Hashimoto's thyroiditis. The unique combination of the composition is preferably administered orally via acid resistant or enteric-coated capsule, soft gel or tablet. The composition is preferably comprised of at least Catalase, Reduced Glutathione, Acetylated Glutathione, DPP-IV protease enzyme, Pepsin, Bromelain, Pancreatin, Vitamin D, and Selenium. The composition can further comprise a palliative agent, and can be provided in specific dosages or administered in forms besides those listed above.

Compositions and Methods for the Treatment of Photoaging and Other Conditions
20170281735 · 2017-10-05 ·

Compositions and methods for the treatment of skin disorders or disease are provided.

SHEET-LIKE WATER-ABSORBING STRUCTURE
20170281418 · 2017-10-05 ·

A sheet-like water-absorbing structure is provided. The aforementioned structure includes: a sheet-like body that includes an absorptive object and elastic material. Meanwhile, the elastic material surrounds the sheet-like body. The fore-and-aft length of the aforementioned structure is longer than its left-and-right width. Two symmetric first connected structures are located at the front end of the aforementioned structure and two symmetric second one are located at the rear end of the aforementioned structure. Meanwhile, the aforementioned structure has no adhesive materials and it relying on the human body by the first connected structure and the second connected structure.

EFFERVESCENT COMPOSITIONS AND METHODS OF MAKING SAME
20170275563 · 2017-09-28 ·

Effervescent compositions are disclosed, particularly effervescent compositions useful in toilet bowls. The effervescent composition may include at least one liquid or solid hydrogen peroxide source and at least one catalyst capable of catalyzing an oxidation of the hydrogen peroxide source in the presence of a liquid, such as water. Accordingly, the effervescent composition is capable of effervescence in the presence of a liquid. The effervescent composition may also include a non-hygroscopic solvent. The presence of the non-hygroscopic solvent may assist the effervescent composition in substantially avoiding effervescence until the composition contacts the liquid. Optionally, the ratio of the hydrogen peroxide source and catalyst to the non-hygroscopic solvent is not less than 9:1.

PROTEIN/OLIGONUCLEOTIDE CORE-SHELL NANOPARTICLE THERAPEUTICS
20170232109 · 2017-08-17 ·

The present disclosure is directed to core-shell nanoparticles, compositions comprising core-shell nanoparticles, and methods of their use.

CHEWABLE LIPID SUPPLEMENTS FOR TREATING PAIN AND FIBROMYALGIA
20170319608 · 2017-11-09 ·

Composition, preferably, in the form of capsules or chewable wafers in quantities suitable for relieving the symptoms of fibromyalgia comprise formulations of phospholipids, specifically identified concentrations of phosphatidylglycerol, phosphatidic acid, phosphatidylethanolamine, phosphatidylcholine, glycolipids and phosphatidylserine along with inulin and other desirable active ingredients are described.

Synthetically Functionalized Living Cells for Targeted Drug Delivery

Uniform, functional polymer patches can be attached to a fraction of the surface area of living individual cells. These surface-modified cells can cross the blood-brain barrier while remaining viable after attachment of the functional patch. Functional payloads carried by the patch can include a drug. The patch can include one or more polyelectrolyte multilayers (PEMs).

METHODS FOR IMPROVING THE AMINO ACID CONTENT OF ANIMAL FEED PRODUCTS

Disclosed are compositions and methods for improving the amino acid content of animal feed byproducts from a dry grind ethanol production facility by reducing the amount of residual reducing sugars that can participate in, e.g., the Maillard reaction.

GENE THERAPY FOR OXIDATIVE STRESS

Compositions and methods for anti-oxidant therapy are provided.

TREATMENT OF INFLAMMATORY BOWEL DISEASES THROUGH ADMINISTRATION OF ENTERIC AEROBIZATION THERAPY
20230270777 · 2023-08-31 ·

Agents, kits, and methods that utilize oxygenation to treat Inflammatory Bowel Disease (IBD) and/or provide prophylaxis against exacerbation of IBD are provided. In several embodiments, the agents, kits, and methods according to several embodiments generate in, or carry to, oxygen in the intestinal lumen to treat IBD and provide prophylaxis against exacerbation of IBD, including those caused by the presence of anaerobic bacteria in the intestine. The agents, kits, and methods provided herein generate an aerobic environment within the intestine to alleviate intestinal inflammation.